The WHO’s COVID-19 Technology Access Pool (C-TAP) and the UN-backed Medicines Patent Pool on Aug. 29 announced a licensing agreement with Taiwan’s Medigen Vaccine Biologics Corp to make the company’s COVID-19 vaccine accessible worldwide to people in need.
This is the first time a Taiwanese vaccine manufacturer has used the WHO patent access model to offer its know-how for a COVID-19 vaccine to the world. WHO Director-General Tedros Adhanom Ghebreyesus expressed his gratitude to Medigen for sharing its patent to support countries in fighting the disease.
Toxicology results, animal and clinical trial data, as well as production data, were required to enter the C-TAP pool, similar to how Taiwanese officials in 2021 assessed and granted emergency use authorization (EUA) for the product.
Minister of Health and Welfare Hsueh Jui-yuan (薛瑞元) said that the WHO’s addition of Medigen’s vaccine, which has been administered more than 3 million times in seven countries, means that the global body has authorized and endorsed a Taiwan-made vaccine, and was an affirmation of the nation’s vaccine industry. This is a validation of Medigen after the harsh criticism it has endured from Taiwanese opposition parties over the past few years.
There are also lessons to learn about the restoration of justice for vaccine development and manufacturing in Taiwan.
During the COVID-19 pandemic, China weaponized vaccines to advance its geopolitical agenda and influence politics in Taiwan. Beijing not only barred vaccines produced by foreign manufacturers and limited its people to its domestic vaccines, it also sought to block Taiwan’s vaccine procurement, including by delaying delivery of an order for BioNTech vaccines. These actions aimed to inflict political damage on President Tsai Ing-wen’s (蔡英文) administration while promoting Chinese-made vaccines to facilitate its “united front” work.
Ironically, despite surveys showing that more than 80 percent of Taiwanese were not willing to be inoculated with China-made vaccines, some opposition politicians, notably from the Chinese Nationalist Party (KMT), and pro-China media influencers badgered the government to buy Chinese vaccines, while lashing out at Taiwan’s domestically produced vaccine and stigmatizing efforts to foster an indigenous biotech industry.
International researchers have shown that Taiwan-made vaccines are effective against COVID-19. A transnational study published in a Swiss medical journal found that Medigen’s vaccine has an efficacy of 84 percent, far better than Chinese vaccines, which were rated only 65 percent effective.
While the Food and Drug Administration was criticized for granting Medigen an EUA based on immunobridging, many WHO-validated vaccines used the same standard to issue EUAs. Studies have also shown that Medigen’s protein subunit vaccine has fewer adverse reactions than mRNA COVID-19 vaccines.
The Medigen story is a reminder that the scientific process should prevail over political mudslinging.
Political attacks have intensified in the run-up to the presidential and legislative elections in January, with slogans such as “Electing the Democratic Progressive Party will cause war” — even as China continues with its military posturing in the Taiwan Strait.
Just as collective immunity against a virus is required to protect public health when a pandemic hits, collective awareness and wisdom are required as the elections draw near to guard against disinformation and stigmatization, and protect Taiwan’s democracy and sovereignty.
George Santayana wrote: “Those who cannot remember the past are condemned to repeat it.” This article will help readers avoid repeating mistakes by examining four examples from the civil war between the Chinese Communist Party (CCP) forces and the Republic of China (ROC) forces that involved two city sieges and two island invasions. The city sieges compared are Changchun (May to October 1948) and Beiping (November 1948 to January 1949, renamed Beijing after its capture), and attempts to invade Kinmen (October 1949) and Hainan (April 1950). Comparing and contrasting these examples, we can learn how Taiwan may prevent a war with
A recent trio of opinion articles in this newspaper reflects the growing anxiety surrounding Washington’s reported request for Taiwan to shift up to 50 percent of its semiconductor production abroad — a process likely to take 10 years, even under the most serious and coordinated effort. Simon H. Tang (湯先鈍) issued a sharp warning (“US trade threatens silicon shield,” Oct. 4, page 8), calling the move a threat to Taiwan’s “silicon shield,” which he argues deters aggression by making Taiwan indispensable. On the same day, Hsiao Hsi-huei (蕭錫惠) (“Responding to US semiconductor policy shift,” Oct. 4, page 8) focused on
Taiwan is rapidly accelerating toward becoming a “super-aged society” — moving at one of the fastest rates globally — with the proportion of elderly people in the population sharply rising. While the demographic shift of “fewer births than deaths” is no longer an anomaly, the nation’s legal framework and social customs appear stuck in the last century. Without adjustments, incidents like last month’s viral kicking incident on the Taipei MRT involving a 73-year-old woman would continue to proliferate, sowing seeds of generational distrust and conflict. The Senior Citizens Welfare Act (老人福利法), originally enacted in 1980 and revised multiple times, positions older
Nvidia Corp’s plan to build its new headquarters at the Beitou Shilin Science Park’s T17 and T18 plots has stalled over a land rights dispute, prompting the Taipei City Government to propose the T12 plot as an alternative. The city government has also increased pressure on Shin Kong Life Insurance Co, which holds the development rights for the T17 and T18 plots. The proposal is the latest by the city government over the past few months — and part of an ongoing negotiation strategy between the two sides. Whether Shin Kong Life Insurance backs down might be the key factor
RSS